Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumab

David J Jackson; Liam G Heaney; Marc Humbert; Brian D Kent; Anat Shavit; Lina Hiljemark; Lynda Olinger; David Cohen; Andrew Menzies-Gow; Stephanie Korn

doi:10.1080/1750743X.2024.2436829

Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumab

David J Jackson
, Liam G Heaney
, Marc Humbert
, Brian D Kent
, Anat Shavit
, Lina Hiljemark
, Lynda Olinger
, David Cohen
, Andrew Menzies-Gow
, Stephanie Korn

Research output: Contribution to journal › Article › peer-review

69 Downloads (Pure)

Original language	English
Pages (from-to)	1175-1184
Number of pages	10
Journal	Immunotherapy
Volume	16
Issue number	20-22
DOIs	https://doi.org/10.1080/1750743X.2024.2436829
Publication status	Published - 09 Jan 2025

Keywords

SHAMAL study
eosinophilic asthma
benralizumab

Access to Document

10.1080/1750743X.2024.2436829Licence: CC BY-NC-ND

Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumab
Copyright 2024 the authors. This is an open access article published under a Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits distribution and reproduction for non-commercial purposes, provided the author and source are cited.
Final published version, 2.26 MBLicence: CC BY-NC-ND

Cite this

@article{8b82d97796e04a9b817b43af97fac5cd,

title = "Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumab",

keywords = "SHAMAL study, eosinophilic asthma, benralizumab",

author = "Jackson, \{David J\} and Heaney, \{Liam G\} and Marc Humbert and Kent, \{Brian D\} and Anat Shavit and Lina Hiljemark and Lynda Olinger and David Cohen and Andrew Menzies-Gow and Stephanie Korn",

year = "2025",

month = jan,

day = "9",

doi = "10.1080/1750743X.2024.2436829",

language = "English",

volume = "16",

pages = "1175--1184",

journal = "Immunotherapy",

issn = "1750-743X",

publisher = "Taylor and Francis",

number = "20-22",

}

TY - JOUR

T1 - Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumab

AU - Jackson, David J

AU - Heaney, Liam G

AU - Humbert, Marc

AU - Kent, Brian D

AU - Shavit, Anat

AU - Hiljemark, Lina

AU - Olinger, Lynda

AU - Cohen, David

AU - Menzies-Gow, Andrew

AU - Korn, Stephanie

PY - 2025/1/9

Y1 - 2025/1/9

KW - SHAMAL study

KW - eosinophilic asthma

KW - benralizumab

U2 - 10.1080/1750743X.2024.2436829

DO - 10.1080/1750743X.2024.2436829

M3 - Article

C2 - 39780731

SN - 1750-743X

VL - 16

SP - 1175

EP - 1184

JO - Immunotherapy

JF - Immunotherapy

IS - 20-22

ER -